{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:34Z","timestamp":1790705854730,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histological inspection of visually normal tissue adjacent to neoplastic lesions often reveals multiple foci of cellular abnormalities. This suggests the presence of a regional carcinogenic signal that spreads oncogenic transformation and field cancerization. We observed an abundance of mutagenic reactive oxygen species in the stroma of cryosectioned patient tumor biopsies, indicative of extratumoral oxidative stress. Diffusible hydrogen peroxide (H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>) was elevated in the conditioned medium of cultured skin epithelia at various stages of oncogenic transformation, and H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> production increased with greater tumor-forming and metastatic capacity of the studied cell lines. Explanted cancer-associated fibroblasts (CAFs) also had higher levels of H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> secretion compared with normal fibroblasts (FIBs). These results suggest that extracellular H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> acts as a field effect carcinogen. Indeed, H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-treated keratinocytes displayed decreased phosphatase and tensin homolog (PTEN) and increased Src activities because of oxidative modification. Furthermore, treating FIBs with CAF-conditioned medium or exogenous H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> resulted in the acquisition of an oxidative, CAF-like state. <jats:italic>In vivo<\/jats:italic>, the proliferative potential and invasiveness of composite tumor xenografts comprising cancerous or non-tumor-forming epithelia with CAFs and FIBs could be attenuated by the presence of catalase. Importantly, we showed that oxidatively transformed FIBs isolated from composite tumor xenografts retained their ability to promote tumor growth and aggressiveness when adoptively transferred into new xenografts. Higher H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> production by CAFs was contingent on impaired TGF<jats:italic>\u03b2<\/jats:italic> signaling leading to the suppression of the antioxidant enzyme glutathione peroxidase 1 (GPX1). Finally, we detected a reduction in Smad3, TAK1 and TGF<jats:italic>\u03b2<\/jats:italic>RII expression in a cohort of 197 clinical squamous cell carcinoma (SCC) CAFs, suggesting that impaired stromal TGF<jats:italic>\u03b2<\/jats:italic> signaling may be a clinical feature of SCC. Our study indicated that CAFs and cancer cells engage redox signaling circuitries and mitogenic signaling to reinforce their reciprocal relationship, suggesting that future anticancer approaches should simultaneously target ligand receptor and redox-mediated pathways.<\/jats:p>","DOI":"10.1038\/cddis.2016.492","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T15:35:07Z","timestamp":1484840107000},"page":"e2562-e2562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress"],"prefix":"10.1038","volume":"8","author":[{"given":"Jeremy Soon Kiat","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Keat","family":"Sng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Phua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Chong","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguan Soon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"BFcddis2016492_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0959-437X(00)00156-8","volume":"11","author":"TD Tlsty","year":"2001","unstructured":"Tlsty TD, Hein PW . Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11: 54\u201359.","journal-title":"Curr Opin Genet Dev"},{"key":"BFcddis2016492_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.coph.2010.06.010","volume":"10","author":"T Udagawa","year":"2010","unstructured":"Udagawa T, Wood M . Tumor-stromal cell interactions and opportunities for therapeutic intervention. Curr Opin Pharmacol 2010; 10: 369\u2013374.","journal-title":"Curr Opin Pharmacol"},{"key":"BFcddis2016492_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcdb.2009.10.010","volume":"21","author":"OE Franco","year":"2010","unstructured":"Franco OE, Shaw AK, Strand DW, Hayward SW . Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2010; 21: 33\u201339.","journal-title":"Semin Cell Dev Biol"},{"key":"BFcddis2016492_CR4","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR . Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002\u20135011.","journal-title":"Cancer Res"},{"key":"BFcddis2016492_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcdb.2009.10.002","volume":"21","author":"M Shimoda","year":"2010","unstructured":"Shimoda M, Mellody KT, Orimo A . Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010; 21: 19\u201325.","journal-title":"Semin Cell Dev Biol"},{"key":"BFcddis2016492_CR6","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH . A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727\u20131730.","journal-title":"Cancer Res"},{"key":"BFcddis2016492_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.yexmp.2012.10.018","volume":"93","author":"AG Rivenbark","year":"2012","unstructured":"Rivenbark AG, Coleman WB . Field cancerization in mammary carcinogenesis - implications for prevention and treatment of breast cancer. Exp Mol Pathol 2012; 93: 391\u2013398.","journal-title":"Exp Mol Pathol"},{"key":"BFcddis2016492_CR8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1172\/JCI72589","volume":"124","author":"GP Dotto","year":"2014","unstructured":"Dotto GP . Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest 2014; 124: 1446\u20131453.","journal-title":"J Clin Invest"},{"key":"BFcddis2016492_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1089\/ars.2009.3020","volume":"13","author":"L Chaiswing","year":"2010","unstructured":"Chaiswing L, Oberley TD . Extracellular\/microenvironmental redox state. Antioxid Redox Signal 2010; 13: 449\u2013465.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2016492_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4161\/cbt.10.6.13370","volume":"10","author":"MP Lisanti","year":"2010","unstructured":"Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker-Menezes D, Tsirigos A et al. Understanding the \"lethal\" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy\/mitophagy in the tumor micro-environment. Cancer Biol Ther 2010; 10: 537\u2013542.","journal-title":"Cancer Biol Ther"},{"key":"BFcddis2016492_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou GY, Storz P . Reactive oxygen species in cancer. Free Radic Res 2010; 44: 479\u2013496.","journal-title":"Free Radic Res"},{"key":"BFcddis2016492_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 981\u2013990.","journal-title":"Cell Signal"},{"key":"BFcddis2016492_CR13","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1089\/ars.2010.3685","volume":"15","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Du Y, Le W, Wang K, Kieffer N, Zhang J . Redox control of the survival of healthy and diseased cells. Antioxid Redox Signal 2011; 15: 2867\u20132908.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2016492_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0003-9861(84)90348-5","volume":"234","author":"MS Baker","year":"1984","unstructured":"Baker MS, Gebicki JM . The effect of pH on the conversion of superoxide to hydroxyl free radicals. Arch Biochem Biophys 1984; 234: 258\u2013264.","journal-title":"Arch Biochem Biophys"},{"key":"BFcddis2016492_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/0003-9861(83)90325-9","volume":"226","author":"MA Takahashi","year":"1983","unstructured":"Takahashi MA, Asada K . Superoxide anion permeability of phospholipid membranes and chloroplast thylakoids. Arch Biochem Biophys 1983; 226: 558\u2013566.","journal-title":"Arch Biochem Biophys"},{"key":"BFcddis2016492_CR16","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1038\/sj.onc.1202934","volume":"18","author":"P Boukamp","year":"1999","unstructured":"Boukamp P, Popp S, Bleuel K, Tomakidi E, B\u00fcrkle A, Fusenig NE . Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 1999; 18: 5638\u20135645.","journal-title":"Oncogene"},{"key":"BFcddis2016492_CR17","doi-asserted-by":"publisher","first-page":"20336","DOI":"10.1074\/jbc.M111899200","volume":"277","author":"SR Lee","year":"2002","unstructured":"Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG . Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 2002; 277: 20336\u201320342.","journal-title":"J Biol Chem"},{"key":"BFcddis2016492_CR18","doi-asserted-by":"publisher","first-page":"16419","DOI":"10.1073\/pnas.0407396101","volume":"101","author":"J Kwon","year":"2004","unstructured":"Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 2004; 101: 16419\u201316424.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016492_CR19","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1128\/MCB.25.15.6391-6403.2005","volume":"25","author":"E Giannoni","year":"2005","unstructured":"Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P . Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 2005; 25: 6391\u20136403.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2016492_CR20","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/ars.2013.5525","volume":"20","author":"E Giannoni","year":"2014","unstructured":"Giannoni E, Chiarugi P . Redox circuitries driving Src regulation. Antioxid Redox Signal 2014; 20: 2011\u20132025.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2016492_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Arron ST, Hanahan D . Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010; 17: 135\u2013147.","journal-title":"Cancer Cell"},{"key":"BFcddis2016492_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.seminoncol.2014.03.002","volume":"41","author":"U Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn U, Sotgia F, Lisanti MP . Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Semin Oncol 2014; 41: 195\u2013216.","journal-title":"Semin Oncol"},{"key":"BFcddis2016492_CR23","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1021\/bi802068s","volume":"48","author":"KL Seldeen","year":"2009","unstructured":"Seldeen KL, McDonald CB, Deegan BJ, Farooq A . Single nucleotide variants of the TGACTCA motif modulate energetics and orientation of binding of the Jun-Fos heterodimeric transcription factor. Biochemistry 2009; 48: 1975\u20131983.","journal-title":"Biochemistry"},{"key":"BFcddis2016492_CR24","doi-asserted-by":"publisher","first-page":"21145","DOI":"10.1074\/jbc.273.33.21145","volume":"273","author":"LJ Jonk","year":"1998","unstructured":"Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W . Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998; 273: 21145\u201321152.","journal-title":"J Biol Chem"},{"key":"BFcddis2016492_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1432-0436.2002.700903.x","volume":"70","author":"MM Mueller","year":"2002","unstructured":"Mueller MM, Fusenig NE . Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002; 70: 486\u2013497.","journal-title":"Differentiation"},{"key":"BFcddis2016492_CR26","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.4161\/cc.25695","volume":"12","author":"MP Lisanti","year":"2013","unstructured":"Lisanti MP, Martinez-Outschoorn UE, Sotgia F . Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and \"fibroblast addiction\" are new therapeutic targets for drug discovery. Cell Cycle 2013; 12: 2723\u20132732.","journal-title":"Cell Cycle"},{"key":"BFcddis2016492_CR27","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase\/AKT pathways. Oncogene 2005; 24: 7443\u20137454.","journal-title":"Oncogene"},{"key":"BFcddis2016492_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1126\/science.286.5440.771","volume":"286","author":"SL Stroschein","year":"1999","unstructured":"Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K . Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 1999; 286: 771\u2013774.","journal-title":"Science"},{"key":"BFcddis2016492_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3892\/ijo.2015.2816","volume":"46","author":"P Papageorgis","year":"2015","unstructured":"Papageorgis P, Stylianopoulos T . Role of TGFbeta in regulation of the tumor microenvironment and drug delivery (review). Int J Oncol 2015; 46: 933\u2013943.","journal-title":"Int J Oncol"},{"key":"BFcddis2016492_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1101\/gad.14.2.187","volume":"14","author":"M Bitzer","year":"2000","unstructured":"Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M et al. A mechanism of suppression of TGF-beta\/SMAD signaling by NF-kappa B\/RelA. Genes Dev 2000; 14: 187\u2013197.","journal-title":"Genes Dev"},{"key":"BFcddis2016492_CR31","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/onc.2012.171","volume":"32","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X et al. TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 2013; 32: 1549\u20131559.","journal-title":"Oncogene"},{"key":"BFcddis2016492_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/JMN:26:1:027","volume":"26","author":"E Kratsovnik","year":"2005","unstructured":"Kratsovnik E, Bromberg Y, Sperling O, Zoref-Shani E . Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures. J Mol Neurosci 2005; 26: 27\u201332.","journal-title":"J Mol Neurosci"},{"key":"BFcddis2016492_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","volume":"72","author":"G Gloire","year":"2006","unstructured":"Gloire G, Legrand-Poels S, Piette J . NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006; 72: 1493\u20131505.","journal-title":"Biochem Pharmacol"},{"key":"BFcddis2016492_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1101\/gad.186965.112","volume":"26","author":"JS Logue","year":"2012","unstructured":"Logue JS, Morrison DK . Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev 2012; 26: 641\u2013650.","journal-title":"Genes Dev"},{"key":"BFcddis2016492_CR35","doi-asserted-by":"publisher","first-page":"9650","DOI":"10.1158\/0008-5472.CAN-10-1146","volume":"70","author":"Y Addadi","year":"2010","unstructured":"Addadi Y, Moskovits N, Granot D, Lozano G, Carmi Y, Apte RN et al. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. Cancer Res 2010; 70: 9650\u20139658.","journal-title":"Cancer Res"},{"key":"BFcddis2016492_CR36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/sj.bjc.6605847","volume":"103","author":"N Tobar","year":"2010","unstructured":"Tobar N, Guerrero J, Smith PC, Martinez J . NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. Br J Cancer 2010; 103: 1040\u20131047.","journal-title":"Br J Cancer"},{"key":"BFcddis2016492_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.bbrc.2013.05.035","volume":"435","author":"J Choi","year":"2013","unstructured":"Choi J, Park SJ, Jo EJ, Lee HY, Hong S, Kim SJ et al. Hydrogen peroxide inhibits transforming growth factor-beta1-induced cell cycle arrest by promoting Smad3 linker phosphorylation through activation of Akt-ERK1\/2-linked signaling pathway. Biochem Biophys Res Commun 2013; 435: 634\u2013639.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2016492_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P et al. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) 2011; 3: 192\u2013222.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2016492_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH . The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245\u2013313.","journal-title":"Physiol Rev"},{"key":"BFcddis2016492_CR40","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1073\/pnas.131200498","volume":"98","author":"B Cao","year":"2001","unstructured":"Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ et al. Neutralizing monoclonal antibodies to hepatocyte growth factor\/scatter factor (HGF\/SF) display antitumor activity in animal models. Proc Natl Acad Sci USA 2001; 98: 7443\u20137448.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016492_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.canlet.2009.10.014","volume":"291","author":"P Zhao","year":"2010","unstructured":"Zhao P, Gao C, Dykema K, Furge K, Feng Z, Cao B et al. Repeated hepatocyte growth factor neutralizing antibody treatment leads to HGF\/SF unresponsiveness in human glioblastoma multiforme cells. Cancer Lett 2010; 291: 209\u2013216.","journal-title":"Cancer Lett"},{"key":"BFcddis2016492_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0065-230X(06)97011-0","volume":"97","author":"A Ostman","year":"2007","unstructured":"Ostman A, Heldin CH . PDGF receptors as targets in tumor treatment. Adv Cancer Res 2007; 97: 247\u2013274.","journal-title":"Adv Cancer Res"},{"key":"BFcddis2016492_CR43","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1158\/1078-0432.CCR-06-0773","volume":"12","author":"PY Wen","year":"2006","unstructured":"Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B et al. Phase I\/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res 2006; 12: 4899\u20134907.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2016492_CR44","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1200\/JCO.2005.03.2185","volume":"23","author":"DA Reardon","year":"2005","unstructured":"Reardon DA, Egorin MJ, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ et al. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol 2005; 23: 9359\u20139368.","journal-title":"J Clin Oncol"},{"key":"BFcddis2016492_CR45","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/annonc\/mdi317","volume":"16","author":"G Dresemann","year":"2005","unstructured":"Dresemann G . Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series. Ann Oncol 2005; 16: 1702\u20131708.","journal-title":"Ann Oncol"},{"key":"BFcddis2016492_CR46","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.3390\/molecules16086232","volume":"16","author":"MZ Koncic","year":"2011","unstructured":"Koncic MZ, Barbaric M, Perkovic I, Zorc B . Antiradical, chelating and antioxidant activities of hydroxamic acids and hydroxyureas. Molecules 16: 6232\u20136242 2011.","journal-title":"Molecules"},{"key":"BFcddis2016492_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","volume":"19","author":"P Zhu","year":"2011","unstructured":"Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011; 19: 401\u2013415.","journal-title":"Cancer Cell"},{"key":"BFcddis2016492_CR48","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1083\/jcb.200809028","volume":"184","author":"HC Chong","year":"2009","unstructured":"Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, Ku CW et al. Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta\/delta is essential for skin homeostasis and wound healing. J Cell Biol 2009; 184: 817\u2013831.","journal-title":"J Cell Biol"},{"key":"BFcddis2016492_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.vascn.2013.07.001","volume":"68","author":"JR Burgoyne","year":"2013","unstructured":"Burgoyne JR, Oviosu O, Eaton P . The PEG-switch assay: a fast semi-quantitative method to determine protein reversible cysteine oxidation. J Pharmacol Toxicol Methods 2013; 68: 297\u2013301.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"BFcddis2016492_CR50","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/cdd.2010.182","volume":"18","author":"CR Lam","year":"2011","unstructured":"Lam CR, Tan MJ, Tan SH, Tang MB, Cheung PC, Tan NS . TAK1 regulates SCF expression to modulate PKBalpha activity that protects keratinocytes from ROS-induced apoptosis. Cell Death Differ 2011; 18: 1120\u20131129.","journal-title":"Cell Death Differ"},{"key":"BFcddis2016492_CR51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/mt.2014.102","volume":"22","author":"HC Chong","year":"2014","unstructured":"Chong HC, Chan JS, Goh CQ, Gounko NV, Luo B, Wang X et al. Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice. Mol Ther 2014; 22: 1593\u20131604.","journal-title":"Mol Ther"},{"key":"BFcddis2016492_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.11.001","volume":"197","author":"X Wang","year":"2015","unstructured":"Wang X, Sng MK, Foo S, Chong HC, Lee WL, Tang MB et al. Early controlled release of peroxisome proliferator-activated receptor beta\/delta agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment. J Control Release 2015; 197: 138\u2013147.","journal-title":"J Control Release"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016492","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:57:25Z","timestamp":1672671445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["BFcddis2016492"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.492","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]},"assertion":[{"value":"14 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}